Cargando…
Metformin inhibits the proliferation of A431 cells by modulating the PI3K/Akt signaling pathway
The ability of metformin, an antidiabetic drug with wide applications, to inhibit tumor cell growth has recently been discovered. The PI3K/Akt signaling pathway has been found to play an important role in the survival, proliferation and apoptosis of tumor cells. The aim of the present study was to e...
Autores principales: | LIU, YINGSHAN, ZHANG, YAN, JIA, KUN, DONG, YUHAO, MA, WEIYUAN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353749/ https://www.ncbi.nlm.nih.gov/pubmed/25780442 http://dx.doi.org/10.3892/etm.2015.2220 |
Ejemplares similares
-
Metformin inhibits the proliferation of A431 cells by modulating the PI3K/Akt signaling pathway
por: Liu, Yingshan, et al.
Publicado: (2022) -
miR-431 regulates granulosa cell function through the IRS2/PI3K/AKT signaling pathway
por: YANG, Lei, et al.
Publicado: (2020) -
Overexpression of CDC42SE1 in A431 Cells Reduced Cell Proliferation by Inhibiting the Akt Pathway
por: Kalailingam, Pazhanichamy, et al.
Publicado: (2019) -
Rapamycin inhibits proliferation and apoptosis of retinoblastoma cells through PI3K/AKT signaling pathway
por: Yao, Jun, et al.
Publicado: (2020) -
Metformin inhibits proliferation of human keratinocytes through a mechanism associated with activation of the MAPK signaling pathway
por: LI, WEINING, et al.
Publicado: (2014)